Research Foundation Announces First Grant Recipients: Researchers from Three Countries Selected to Receive Funding to Investigate Causes of and Treatments for Job Syndrome

(NEW YORK CITY, NY/April 16, 2019) – The Job Research Foundation has announced the recipients of its first round of grant funding that will support investigation into the causes of and treatments for Job Syndrome.

 The Foundation awarded three two-year grants of $200,000 each to support three research projects that will take place around the globe in three countries, and on three continents. The recipients are:

  • Professor Stuart Tangye, Head, Immunology & Immunodeficiency Lab, Garvan Institute of Medical Research (Australia)

  • Dr.  Bertrand Boisson, PhD, St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University (USA)

  • Dr. Peter Olbrich, MD, PhD, Principal Investigator/Pediatric Infectious Diseases and Immunodeficiency Unit, and Dr. Olaf Neth MD, PhD, Principal Investigator and Head of Department/Pediatric Infectious Diseases and Immunodeficiency Unit; Pediatric Infectious Diseases and Immunodeficiency Unit, Hospital Infantil Virgen del Rocio, Sevilla (Spain)

The Job Research Foundation seeks to not only help find a cure for Job Syndrome by providing the scientific community with additional opportunities to further research into the rare multisystem immunodeficiency disorder, but also hopes that investigators will research treatments to help those suffering with Job Syndrome.  

Job Syndrome, also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), was discovered in 1966 and is a multisystem immunodeficiency disorder found in males and females worldwide.

Vance Klein